AAAAAA
Results: 1-25/27
Authors:
SPIER RE
Citation: Re. Spier, ETHICAL ASPECTS OF VACCINES AND VACCINATION, Vaccine, 16(19), 1998, pp. 1788-1794
Authors:
SPIER RE
Citation: Re. Spier, ANIMAL AND PLANT-CELL TECHNOLOGY - A CRITICAL-EVALUATION OF THE TECHNOLOGY SOCIETY INTERFACE/, Journal of biotechnology, 65(2-3), 1998, pp. 111-125
Authors:
KADOURI A
SPIER RE
Citation: A. Kadouri et Re. Spier, SOME MYTHS AND MESSAGES CONCERNING THE BATCH AND CONTINUOUS-CULTURE OF ANIMAL-CELLS, Cytotechnology, 24(2), 1997, pp. 89-98
Authors:
SPIER RE
Citation: Re. Spier, FACTORS LIMITING THE COMMERCIAL APPLICATION OF ANIMAL-CELLS IN CULTURE, Cytotechnology, 23(1-3), 1997, pp. 113-117
Authors:
SPIER RE
Citation: Re. Spier, INFECTIOUS-DISEASE ON THE RUN - A REPORT ON THE CHILDRENS VACCINE INITIATIVE (CVI) - CONSULTATIVE GROUP MEETING, DAKAR, SENEGAL, 9-10 DECEMBER 1996, Vaccine, 15(14), 1997, pp. 1489-1490
Authors:
SPIER RE
Citation: Re. Spier, CVI AWARDS CELEBRATE THE YEAR OF THE VACCINE AND RECENT CONTRIBUTIONSIN IMMUNIZATION AND VACCINE DEVELOPMENT, Vaccine, 15(14), 1997, pp. 1491-1493
Authors:
SPIER RE
Citation: Re. Spier, INTRODUCING FENCE VACCINES, Vaccine, 15(12-13), 1997, pp. 1289-1290
Authors:
SPIER RE
Citation: Re. Spier, THE 3RD EUROPEAN CONFERENCE ON VACCINOLOGY - BUILDING LIFELONG IMMUNITY, BERLIN, 16-18 OCTOBER 1996, Vaccine, 15(11), 1997, pp. 1163-1164
Authors:
SPIER RE
KADOURI A
Citation: Re. Spier et A. Kadouri, THE EVOLUTION OF PROCESSES FOR THE COMMERCIAL EXPLOITATION OF ANCHORAGE-DEPENDENT ANIMAL-CELLS, Enzyme and microbial technology, 21(1), 1997, pp. 2-8
Authors:
SPIER RE
Citation: Re. Spier, MULTIVALENT VACCINES - PROSPECTS AND CHALLENGES, Folia microbiologica, 42(2), 1997, pp. 105-112
Authors:
SPIER RE
Citation: Re. Spier, JENNER JABS PHIPPS,JAMES WITH LIVE COWPOX, Vaccine, 14(17-18), 1996, pp. 1-1
Authors:
SPIER RE
Citation: Re. Spier, INTERNATIONAL MEETING ON THE NUCLEIC-ACID VACCINES FOR THE PREVENTIONOF INFECTIOUS-DISEASE AND REGULATING NUCLEIC-ACID (DNA) VACCINES, Vaccine, 14(13), 1996, pp. 1285-1288
Authors:
SPIER RE
Citation: Re. Spier, SALK,JONAS - OBITUARY, Vaccine, 13(16), 1995, pp. 1487-1487
Authors:
SPIER RE
Citation: Re. Spier, REPORT OF A MEETING ON VACCINES - NEW TECHNOLOGIES AND APPLICATIONS -HELD AT THE RADISSON-PLAZA-HOTEL AT MARK-CENTER, ALEXANDRIA, VIRGINIABY THE CAMBRIDGE-HEALTHTECH-INSTITUTE, 20-22 MARCH 1995, Vaccine, 13(11), 1995, pp. 1038-1039
Authors:
SPIER RE
Citation: Re. Spier, NUCLEIC-ACID VACCINES, Vaccine, 13(1), 1995, pp. 131-132
THE PROCEEDINGS OF OF AN INTERNATIONAL-CONGRESS ON HEPATITIS-B - THE STORY OF AN UNFINISHED BUSINESS
Authors:
SPIER RE
Citation: Re. Spier, THE PROCEEDINGS OF OF AN INTERNATIONAL-CONGRESS ON HEPATITIS-B - THE STORY OF AN UNFINISHED BUSINESS, Vaccine, 13, 1995, pp. 4-4
Authors:
BELL SL
BEBBINGTON C
SCOTT MF
WARDELL JN
SPIER RE
BUSHELL ME
SANDERS PG
Citation: Sl. Bell et al., GENETIC-ENGINEERING OF HYBRIDOMA GLUTAMINE-METABOLISM, Enzyme and microbial technology, 17(2), 1995, pp. 98-106
Authors:
SPIER RE
Citation: Re. Spier, GRADIENTS IN ANIMAL AND PLANT-CELL TECHNOLOGY SYSTEMS, Enzyme and microbial technology, 17(1), 1995, pp. 91-92
Authors:
SPIER RE
Citation: Re. Spier, DEMOCRATIC GOVERNMENTS AND VACCINES, Vaccine, 12(15), 1994, pp. 1363-1363
Authors:
SPIER RE
Citation: Re. Spier, INTERNATIONAL-SOCIETY-FOR-VACCINES (ISV) MEETING - 22-23-MAY-1994, LAS-VEGAS, NV, USA, Vaccine, 12(14), 1994, pp. 1358-1359
Authors:
SPIER RE
Citation: Re. Spier, INTRODUCING THE INTERNATIONAL SOCIETY FOR VACCINES, Vaccine, 12(11), 1994, pp. 1052-1052
Authors:
BUSHELL ME
BELL SL
SCOTT MF
SPIER RE
WARDELL JN
SANDERS PG
Citation: Me. Bushell et al., ENHANCEMENT OF MONOCLONAL-ANTIBODY YIELD BY HYBRIDOMA FED-BATCH CULTURE, RESULTING IN EXTENDED MAINTENANCE OF VIABLE CELL-POPULATION, Biotechnology and bioengineering, 44(9), 1994, pp. 1099-1106
Authors:
MODHA K
WHITESIDE JP
SPIER RE
Citation: K. Modha et al., THE DETERMINATION OF CELLULAR VIABILITY OF HYBRIDOMA CELLS IN MICROTITRE PLATES - A COLORIMETRIC ASSAY BASED ON NEUTRAL RED, Cytotechnology, 13(3), 1993, pp. 227-232
Authors:
SPIER RE
Citation: Re. Spier, A REPORT ON THE MEETING OF THE EUROPEAN-SOCIETY-FOR-ANIMAL-CELL-TECHNOLOGY (ESACT), HELD IN WURZBURG, GERMANY ON 17-23 MAY, 1993, Cytotechnology, 13(1), 1993, pp. 61-65
Authors:
SPIER RE
Citation: Re. Spier, MODERN APPROACHES TO NEW VACCINES, INCLUDING PREVENTION OF AIDS - 16-22 SEPTEMBER 1992, COLD SPRING HARBOR, LONG-ISLAND, NY, USA, Vaccine, 11(7), 1993, pp. 789-790